GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Haleon HLN.L · GBp

Consumer Staples · Personal Care Products · LSE · 🇬🇧 United Kingdom

FTSE 100

Compare

330.80p

-2.39%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Haleon — daily LSE:HLN

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Haleon on TradingView ↗
Market value
£29.14bn
Last close × shares
Volume
44.9m
Shares, 9 Nov 2026
Price to earnings
1749.3
Dividend yield
0.02%

About Haleon

Its shares trade on LSE under the ticker HLN.L. It has been listed since 18 July 2022. It is a member of the FTSE 100. In the fiscal year to 31 December 2025, it reported revenue of £11.03bn and net income of £1.67bn. At that date it held total assets of £32.63bn and shareholders' equity of £16.43bn.

Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Brentford, Middlesex. The company went IPO on 2022-07-18. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Figures and description from our data supplier, not checked against the company's own report.

More about Haleon →

Latest on Haleon

Our reporting

Next results

4 Mar 2027

Due on 4 Mar 2027. Analysts expect earnings of 0.10 a share.

Other Consumer Staples listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Haleon's ticker?

Haleon trades as HLN.L on LSE, under ISIN GB00BMX86B70.

What was Haleon's last closing price?

330.80p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Haleon next report results?

Results are expected on 4 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.